青益纯医药-健康医药原料一体化生产供应服务商
A beneficial effect of naringin was observed in LDLR-null mice fed a high-fat diet . Mice lacking the LDLR, when fed a Western-style diet, displayed many features of insulin resistance, including VLDL overproduction, dyslipidemia, and obesity . In that study, naringenin (1% or 3% wt:wt of diet) prevented hyperinsulinemia, leading to a reduction in hepatic sterol regulatory element binding protein (SREBP) 1c and hepatic lipogenesis in the fasted state . The reduction in hepatic TG availability due to naringenin supplementation also contributed to VLDL-TG production and VLDL-apoB secretion and attenuated dyslipidemia . A recent investigation also showed that naringin supplementation in high-fat/high-carbohydrate-diet–fed obese rats ameliorated the increase in plasma cholesterol, TGs, and circulating FFAs . In a clinical trial, naringin supplementation (400 mg · capsule−1 · d−1) reduced plasma total- and LDL-cholesterol concentrations, whereas plasma TG and HDL-cholesterol concentrations remained unaffected in hypercholesterolemic patients.
如果你想知道更多信息,可以发邮件到:info@benepure.com或打电话给我们:+862886799990.
电话:+86 28 8679 9990 +86 28 8679 8880 | |
传真:+86 28 8679 9924 | |
邮箱:info@benepure.cn | |
地址:中国 · 成都市高新区吉瑞三路99号 |
Linkedln | |
Skype | |
TencentQQ | |
SinaWeibo | |